| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8936001 | British Journal of Anaesthesia | 2011 | 8 Pages |
Abstract
A single slow infusion of nefopam is effective in critically ill patients who have moderate pain. The risk of tachycardia and increased cardiac output and also hypotension and decreased systemic vascular resistance should be known to evaluate the benefit/risk ratio of its prescription.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
G Chanques, M Sebbane, J.M. Constantin, N Ramillon, B Jung, M Cissé, J.Y. Lefrant, S Jaber,